‘‘(4) Based on the outcome of counseling under 
paragraph (3), as the patient is interested, provide 
contraception free from coercion, including hormonal 
contraception medication and devices, barrier contra-
ception, and emergency contraception. 
‘‘(5) Administering telehealth services, which 
may include audio, video, and text messaging serv-
ices. 
‘‘(6) Contracting or hiring clinical and nonclin-
ical support staff, and other relevant health care 
personnel. 
‘‘(7) Creating and disseminating medically-ac-
curate, culturally- and linguistically-appropriate, ac-
cessible educational materials and resources on con-
traception and contraceptive care for patients. 
‘‘(8) Interpretation and translation services. 
‘‘(9) Contraception referrals and counseling. 
‘‘(10) Follow-up contraceptive care, including 
the management, evaluation, and changes, including 
the removal, continuation, and discontinuation, of 
contraception. 
‘‘(e) APPLICATION.—To seek a grant under this sec-
tion, an eligible entity shall submit an application to the 
Secretary at such time, in such manner, and containing 
such information as the Secretary may require, including 
VerDate Sep 11 2014 
16:22 Oct 08, 2024
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H9807.IH
H9807
ssavage on LAPJG3WLY3PROD with BILLS
a plan for increasing capacity as described in subsection 
(a). 
‘‘(f) PROHIBITION AGAINST EXCLUSION OF QUALI-
FIED ELIGIBLE ENTITIES.—No Federal agency, grantee, 
subrecipient, or other entity shall, in the course of admin-
istering or carrying out any program or activity under this 
section, act in a manner which has the effect of excluding, 
limiting, or restricting the participation of any entity that 
would otherwise be eligible to apply for funds, on the basis 
of any factor unrelated to the entity’s qualifications to ef-
fectively carry out the program or activity. 
‘‘(g) DEFINITIONS.—In this section: 
‘‘(1) CONTRACEPTIVE CARE.—The term ‘con-
traceptive care’ means education, person-centered 
counseling, and provision of any method of contra-
ception approved, granted marketing authorization, 
or cleared under the Federal Food Drug, and Cos-
metic Act, or licensed under section 351 of this Act, 
including emergency contraception. 
‘‘(2) CONTRACEPTION.—The term ‘contracep-
tion’ means a device, medication, procedure, or be-
havior that is intended to prevent pregnancy. Such 
term includes any device, medication, procedure, or 
behavior listed in the most recently published Birth 
VerDate Sep 11 2014 
16:22 Oct 08, 2024
Jkt 059200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H9807.IH
H9807
ssavage on LAPJG3WLY3PROD with BILLS
Control Guide published by the Food and Drug Ad-
ministration, including— 
‘‘(A) sterilization surgery for women; 
‘‘(B) implantable rods; 
‘‘(C) copper intrauterine devices; 
‘‘(D) intrauterine devices with progestin; 
‘‘(E) injectable contraceptives; 
‘‘(F) oral contraceptives (combined pill); 
‘‘(G) oral contraceptives (progestin only); 
‘‘(H) oral contraceptives (extended or con-
tinuous use); 
‘‘(I) contraceptive patch; 
‘‘(J) vaginal contraceptive rings; 
‘‘(K) diaphragms; 
‘‘(L) contraceptive sponges; 
‘‘(M) cervical caps; 
‘‘(N) condoms; 
‘‘(O) spermicides; 
‘‘(P) 
emergency 
contraception 
(levonorgestrel); 
‘‘(Q) emergency contraception (ulipristal 
acetate); and 
‘‘(R) any additional contraceptives ap-
proved, granted marketing authorization, or 
cleared under the Federal Food, Drug, and 
VerDate Sep 11 2014 
16:22 Oct 08, 2024
Jkt 059200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H9807.IH
H9807
ssavage on LAPJG3WLY3PROD with BILLS
Cosmetic Act or licensed under section 351 of 
this Act. 
‘‘(h) AUTHORIZATION
OF
APPROPRIATIONS.—To 
carry out this section, there is authorized to be appro-
priated $100,000,000 for each of fiscal years 2025 
through 2029.’’. 
Æ 
VerDate Sep 11 2014 
16:22 Oct 08, 2024
Jkt 059200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6301
E:\BILLS\H9807.IH
H9807
ssavage on LAPJG3WLY3PROD with BILLS